ADCs (Antibody Drug Conjugates) target tumor cells while ignoring the healthy cells. These complex molecules are comprised of a vector (the antibody), linker, and highly potent/cytotoxic payload or warhead. Eurofins BioPharma Product Testing network of laboratories has experience developing and validating tests unique to ADCs, include free drug, free antibody, and drug/antibody ratio (DAR) in our OEL/CAT 5 labs.